Literature DB >> 10479473

Inhibition by levamisole of the organic cation transporter rOCT1 in cultured rat hepatocytes.

F Martel1, L Ribeiro, C Calhau, I Azevedo.   

Abstract

Levamisole is known to be subject to hepatic removal and metabolism and to biliary excretion. The aim of our work was to study the mechanism involved in the removal of this compound by the liver. For this purpose, we studied the influence of levamisole on the uptake and efflux of the model organic cation 1-methyl-4-phenylpyridinium (MPP(+)) by primary cultured rat hepatocytes. Levamisole (500 microm) was found to produce a strong inhibition (to 31+/-2% of control) of [(3)H]MPP(+)uptake. Moreover, efflux of [(3)H]MPP(+)was also potently reduced by levamisole (500 microm). Our results show that levamisole interferes with an hepatic organic cation transporter which accepts MPP(+)as a substrate. This mechanism most probably corresponds to rOCT1, and it might be responsible for the hepatic removal of levamisole from the blood circulation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479473     DOI: 10.1006/phrs.1999.0506

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Effect of liniment levamisole on cellular immune functions of patients with chronic hepatitis B.

Authors:  Ke-Xia Wang; Li-Hua Zhang; Jiang-Long Peng; Yong Liang; Xue-Feng Wang; Hui Zhi; Xiang-Xia Wang; Huan-Xiong Geng
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndrome.

Authors:  Lieke A Hoogenboom; Hazel Webb; Kjell Tullus; Aoife Waters
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.714

3.  Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C.

Authors:  Floor Veltkamp; Arend Bökenkamp; Jeroen Slaats; Henrike Hamer; Antonia H M Bouts
Journal:  Pediatr Nephrol       Date:  2022-04-13       Impact factor: 3.651

4.  TNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties.

Authors:  Barbara Deracinois; Sophie Duban-Deweer; Gwënaël Pottiez; Roméo Cecchelli; Yannis Karamanos; Christophe Flahaut
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 5.  Membrane transporters as mediators of Cisplatin effects and side effects.

Authors:  Giuliano Ciarimboli
Journal:  Scientifica (Cairo)       Date:  2012-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.